The term sarcopenia was introduced in 1988. The original definition was a “muscle loss” of
the appendicular muscle mass in the older people as measured by dual energy x‐ray …

Cancer cachexia is a multifactorial syndrome characterized by a progressive loss of skeletal
muscle mass, along with adipose tissue wasting, systemic inflammation and other metabolic …

Objective The task force of the International Conference of Frailty and Sarcopenia Research
(ICFSR) developed these clinical practice guidelines to overview the current evidence-base …

Abstract The new ICD‐10‐CM (M62. 84) code for sarcopenia represents a major step
forward in recognizing sarcopenia as a disease. This should lead to an increase in …

Body composition measurements from DXA have been available since DXA technology was
developed 30 years ago, but are historically underutilized. Recently, there have been rapid …

Sarcopenia is a progressive and generalized loss of skeletal muscle mass and function. The
prevalence of sarcopenia was reported to be up to 29% in older persons in the community …

Background A brief, inexpensive screening test for sarcopenia would be helpful for clinicians
and their patients. To screen for persons with sarcopenia, we developed a simple five‐item …

Sarcopenia is an age‐related disease and is often accompanied by other diseases. Now,
many studies have shown that cardiovascular diseases (CVDs) may raise the incidence rate …

Objective: to examine the clinical evidence reporting the prevalence of sarcopenia and the
effect of nutrition and exercise interventions from studies using the consensus definition of …

Life expectancy is increasing worldwide, with a resultant increase in the elderly population.
Aging is characterized by the progressive loss of skeletal muscle mass and strength–a …